139 related articles for article (PubMed ID: 37348629)
1. STAT3 as a newly emerging target in colorectal cancer therapy: Tumorigenesis, therapy response, and pharmacological/nanoplatform strategies.
Hashemi M; Abbaszadeh S; Rashidi M; Amini N; Talebi Anaraki K; Motahhary M; Khalilipouya E; Harif Nashtifani A; Shafiei S; Ramezani Farani M; Nabavi N; Salimimoghadam S; Aref AR; Raesi R; Taheriazam A; Entezari M; Zha W
Environ Res; 2023 Sep; 233():116458. PubMed ID: 37348629
[TBL] [Abstract][Full Text] [Related]
2. PDCD4 Deficiency Aggravated Colitis and Colitis-associated Colorectal Cancer Via Promoting IL-6/STAT3 Pathway in Mice.
Wang L; Zhao M; Guo C; Wang G; Zhu F; Wang J; Wang X; Wang Q; Zhao W; Shi Y; Chen YH; Zhang L
Inflamm Bowel Dis; 2016 May; 22(5):1107-18. PubMed ID: 26891257
[TBL] [Abstract][Full Text] [Related]
3. Spica prunellae promotes cancer cell apoptosis, inhibits cell proliferation and tumor angiogenesis in a mouse model of colorectal cancer via suppression of stat3 pathway.
Lin W; Zheng L; Zhuang Q; Zhao J; Cao Z; Zeng J; Lin S; Xu W; Peng J
BMC Complement Altern Med; 2013 Jun; 13():144. PubMed ID: 23800091
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-124-3p suppresses PD-L1 expression and inhibits tumorigenesis of colorectal cancer cells via modulating STAT3 signaling.
Roshani Asl E; Rasmi Y; Baradaran B
J Cell Physiol; 2021 Oct; 236(10):7071-7087. PubMed ID: 33821473
[TBL] [Abstract][Full Text] [Related]
5. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.
Liu H; Ren G; Wang T; Chen Y; Gong C; Bai Y; Wang B; Qi H; Shen J; Zhu L; Qian C; Lai M; Shao J
Carcinogenesis; 2015 Apr; 36(4):459-68. PubMed ID: 25750173
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of SLC9A8 Promotes Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer Cells via the IL6-JAK1/STAT3 Signaling Pathway.
Liu W; Geng C; Li X; Li Y; Song S; Wang C
Dig Dis Sci; 2023 May; 68(5):1873-1884. PubMed ID: 36583805
[TBL] [Abstract][Full Text] [Related]
7. Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition.
Xiong H; Hong J; Du W; Lin YW; Ren LL; Wang YC; Su WY; Wang JL; Cui Y; Wang ZH; Fang JY
J Biol Chem; 2012 Feb; 287(8):5819-32. PubMed ID: 22205702
[TBL] [Abstract][Full Text] [Related]
8. Aloperine inhibits colorectal cancer cell proliferation and metastasis progress via regulating miR-296-5p/STAT3 axis.
Han W; Kong D; Lu Q; Zhang W; Fan Z
Tissue Cell; 2022 Feb; 74():101706. PubMed ID: 34883316
[TBL] [Abstract][Full Text] [Related]
9. Antagonistic Effects of p53 and HIF1A on microRNA-34a Regulation of PPP1R11 and STAT3 and Hypoxia-induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells.
Li H; Rokavec M; Jiang L; Horst D; Hermeking H
Gastroenterology; 2017 Aug; 153(2):505-520. PubMed ID: 28435028
[TBL] [Abstract][Full Text] [Related]
10. RP11-296E3.2 acts as an important molecular chaperone for YBX1 and promotes colorectal cancer proliferation and metastasis by activating STAT3.
Shi Q; He Y; He S; Li J; Xia J; Chen T; Huo L; Ling Y; Liu Q; Zang W; Wang Q; Tang C; Wang X
J Transl Med; 2023 Jun; 21(1):418. PubMed ID: 37370092
[TBL] [Abstract][Full Text] [Related]
11. Aloperine Inhibits Proliferation and Promotes Apoptosis in Colorectal Cancer Cells by Regulating the circNSUN2/miR-296-5p/STAT3 Pathway.
Han W; Kong D; Lu Q; Zhang W; Fan Z
Drug Des Devel Ther; 2021; 15():857-870. PubMed ID: 33664565
[TBL] [Abstract][Full Text] [Related]
12. GRIM-19 repressed hypoxia-induced invasion and EMT of colorectal cancer by repressing autophagy through inactivation of STAT3/HIF-1α signaling axis.
Zhang J; Chu D; Kawamura T; Tanaka K; He S
J Cell Physiol; 2019 Aug; 234(8):12800-12808. PubMed ID: 30537081
[TBL] [Abstract][Full Text] [Related]
13. STIP1 knockdown suppresses colorectal cancer cell proliferation, migration and invasion by inhibiting STAT3 pathway.
Xia Y; Chen J; Liu G; Huang W; Wei X; Wei Z; He Y
Chem Biol Interact; 2021 May; 341():109446. PubMed ID: 33766539
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of PYCR1 inhibits proliferation, drug resistance and EMT in colorectal cancer cells by regulating STAT3-Mediated p38 MAPK and NF-κB signalling pathway.
Yan K; Xu X; Wu T; Li J; Cao G; Li Y; Ji Z
Biochem Biophys Res Commun; 2019 Dec; 520(2):486-491. PubMed ID: 31606203
[TBL] [Abstract][Full Text] [Related]
15. Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth.
De Simone V; Franzè E; Ronchetti G; Colantoni A; Fantini MC; Di Fusco D; Sica GS; Sileri P; MacDonald TT; Pallone F; Monteleone G; Stolfi C
Oncogene; 2015 Jul; 34(27):3493-503. PubMed ID: 25174402
[TBL] [Abstract][Full Text] [Related]
16. Pien Tze Huang inhibits tumor cell proliferation and promotes apoptosis via suppressing the STAT3 pathway in a colorectal cancer mouse model.
Zhuang Q; Hong F; Shen A; Zheng L; Zeng J; Lin W; Chen Y; Sferra TJ; Hong Z; Peng J
Int J Oncol; 2012 May; 40(5):1569-74. PubMed ID: 22218594
[TBL] [Abstract][Full Text] [Related]
17. Carboxypeptidase A4 promotes cell growth via activating STAT3 and ERK signaling pathways and predicts a poor prognosis in colorectal cancer.
Pan H; Pan J; Ji L; Song S; Lv H; Yang Z; Guo Y
Int J Biol Macromol; 2019 Oct; 138():125-134. PubMed ID: 31279884
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of TRIM66 inhibits cell proliferation, migration and invasion in colorectal cancer through JAK2/STAT3 pathway.
He T; Cui J; Wu Y; Sun X; Chen N
Life Sci; 2019 Oct; 235():116799. PubMed ID: 31472144
[TBL] [Abstract][Full Text] [Related]
19. The JAK2/STAT3/CCND2 Axis promotes colorectal Cancer stem cell persistence and radioresistance.
Park SY; Lee CJ; Choi JH; Kim JH; Kim JW; Kim JY; Nam JS
J Exp Clin Cancer Res; 2019 Sep; 38(1):399. PubMed ID: 31511084
[TBL] [Abstract][Full Text] [Related]
20. STAT3 regulates 5-Fu resistance in human colorectal cancer cells by promoting Mcl-1-dependent cytoprotective autophagy.
Yue Y; Zhang Q; Wang X; Sun Z
Cancer Sci; 2023 Jun; 114(6):2293-2305. PubMed ID: 36788743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
